NCT05538897 2026-04-13Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial CancersNational Cancer Institute (NCI)Phase 1/2 Active not recruiting96 enrolled